INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 283 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,712,048 | +79.5% | 370,400 | +131.5% | 0.05% | -2.1% |
| Q2 2023 | $6,524,800 | -56.2% | 160,000 | -60.0% | 0.05% | -27.7% |
| Q1 2023 | $14,908,000 | +105.3% | 400,000 | +92.2% | 0.06% | -12.2% |
| Q4 2022 | $7,260,609 | +765.4% | 208,100 | +1287.3% | 0.07% | +957.1% |
| Q3 2022 | $839,000 | -76.9% | 15,000 | -78.7% | 0.01% | -75.0% |
| Q2 2022 | $3,639,000 | -22.2% | 70,300 | +9.2% | 0.03% | -55.6% |
| Q1 2022 | $4,680,000 | +31.9% | 64,400 | +114.7% | 0.06% | +75.0% |
| Q4 2021 | $3,547,000 | +51.1% | 30,000 | +71.4% | 0.04% | +12.5% |
| Q3 2021 | $2,348,000 | – | 17,500 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Discovery Value Fund | 561,561 | $17,756,559 | 9.73% |
| MPM BioImpact LLC | 544,639 | $17,221,485 | 4.60% |
| Casdin Capital, LLC | 1,178,075 | $37,250,732 | 4.12% |
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,145,091 | $36,207,777 | 3.72% |
| Atlas Venture Associates IX, LLC | 10,000 | $316,200 | 2.69% |
| Deep Track Capital, LP | 2,000,000 | $63,240,000 | 2.44% |
| ARK Investment Management | 9,948,629 | $314,575,638 | 2.41% |
| Merlin Capital, Inc | 18,526 | $585,792 | 2.19% |
| Orchard Capital Management, LLC | 159,155 | $5,032,481 | 1.86% |
| TANG CAPITAL MANAGEMENT LLC | 397,600 | $12,572,112 | 1.77% |